位置:成果数据库 > 期刊 > 期刊详情页
不同部位胰腺癌的误诊分析
  • ISSN号:1001-5930
  • 期刊名称:实用癌症杂志
  • 时间:2012
  • 页码:153-154+170
  • 分类:R392[医药卫生—免疫学;医药卫生—基础医学]
  • 作者机构:[1]承德市第三医院药剂科, 中国人民解放军沈阳军区总医院消化科,河北承德067000, [2]中国人民解放军沈阳军区总医院消化科
  • 相关基金:国家自然科学基金(81071982)
  • 相关项目:KAI1基因调控胰腺癌自噬作用与机制研究
中文摘要:

目的:建立胰腺癌MiaPaCa-2细胞与树突细胞( DC)融合的细胞,观察其体外诱导胰腺癌肿瘤抗原特异性细胞毒T淋巴细胞( CTL)的能力。方法自胰腺癌患者外周血单核细胞中分离和培养DC,利用50%PEG-10%DMSO融合剂将MiaPaCa-2细胞融合到DC,以不加融合剂仅将DC与MiaPaCa-2共培养组及单纯DC组作为对照。采用FITC-CD86及PE-MUC1进行双标记,上流式细胞仪检测细胞融合率;MTT法检测各组DC存活率。按照DC与T淋巴细胞1∶10、1∶20、1∶40、1∶80的比例混合培养细胞,评价各组DC体外刺激自体T淋巴细胞的增殖能力;ELISA法检测各组DC体外激发的CTL的IL-2、IL-10、Granzyme B、IFN-γ分泌量。结果 DC与MiaPaCa-2融合细胞组的融合率为(42.30±7.30)%,明显高于共培养组的(7.21±1.06)%。 DC组、共培养组、融合细胞组DC的存活率分别为95.0%以上、85.0%、62.8%,融合细胞组 DC 存活率显著低于 DC 组及共培养组,差异有统计学意义( P 值均<0.05)。 DC∶T淋巴细胞为1∶10时,DC组、共培养组、融合细胞组DC刺激自体T细胞增殖指数分别为219±42、3584±317、8201±424,1∶20时分别为110±14、2179±104、6152±104,融合细胞组显著高于DC组及共培养组,差异均有统计学意义( P值均<0.05);为1∶40、1∶80时3组细胞的T细胞增殖指数差异无统计学意义( P值均>0.05)。 DC∶T淋巴细胞为1∶10时,DC组、共培养组、融合细胞组DC激发的CTL的IL-2分泌量分别为(27.30±5.21)、(897.44±93.05)、(2243.80±381.46)ng/L;IL-10分泌量分别为(19.55±2.05)、(424.60±108.25)、(706.53±161.29) ng/L;Granzyme B 分泌量为(16.23±1.23)、(451.07±120.50)、(1327.77±205.15) ng/L;IFN-γ分泌量为(30.11±4.32)、(982.00±124.68)、(2421.04±488.50)ng/L。融合细胞组激发的CTL的?

英文摘要:

Objective To investigate the ability of inducing antigen-specific cytotoxic T lymphocytes (CTL) stimulated by dendritic cell (DC) fused with MiaPaCa-2 cells in vitro.Methods DC were isolated and cultured from peripheral blood mononuclear cells (PBMCs).50%PEG and 10%DMSO were used to fuse MiaPaCa-2 cells and DC, and DC co-cultured with MiaPaCa-2 cells and DC alone served as control .The fusion efficiency was assessed by flow cytometry ( FCM) and DC-MiaPaCa-2 hybrids were identified as PE-MUC1/FITC-CD86 double positive cells . The survival rate of DC was determined by MTT method . The lymphocyte proliferation stimulated by DC in vitro was evaluated by mixed cell culture with DC in different ratios of 1∶10, 1∶20 and 1∶80.IL-2, IL-10, granzyme B and IFN-γreleased by antigen-specific CTLs were measured by ELISA assay.Results The fusion rate in DC fused with MiaPaCa-2 cells ( fused cells ) was ( 42 .30 ± 7.30)%, which was higher than (7.21 ±1.06)% in DC co-cultured with MiaPaCa-2 cells ( co-cultured cells).The cell viability of DC, co-cultured cells and fused cells was >95.0%, 85.0% and 62.8%, and fused cells had greatly lower cell viability than DC and co-cultured cells (P<0.05).When DC and T cells were co-cultured at the ratio of 1∶10, T cell proliferation index in DC , co-cultured and fused cells was 219 ± 42, 3 584 ±317, 8 201 ±424, respectively.At the ratio of 1∶20, T cell proliferation index was 110 ±14, 2 179 ±104 , 6 152 ±104 .T cell proliferation index was higher in fused cells than that in DC and co-cultured cells (both P<0.05) at the ratio of 1∶10 and 1∶20, while the difference was not statistically significant at the ratio of 1∶40 and 1∶80 (P>0.05).At the co-culture ratio of 1∶10, IL-2 secreted by CTL in DC, co-cultured and fused cells was (27.30 ±5.21 ),(897.44 ±93.05),(2 243.80 ±381.46) ng/L; IL-10 was (19.55 ± 2.05), ( 424.60 ±108.25 ), ( 706.53 ±161.29 ) ng/L; Granzyme B was ( 16.

同期刊论文项目
期刊论文 42 会议论文 1 著作 1
同项目期刊论文
期刊信息
  • 《实用癌症杂志》
  • 中国科技核心期刊
  • 主管单位:江西省卫生厅
  • 主办单位:江西省肿瘤医院
  • 主编:黄欧平
  • 地址:江西省南昌市北京东路519号
  • 邮编:330029
  • 邮箱:syazzz@163.net
  • 电话:0791-88329442
  • 国际标准刊号:ISSN:1001-5930
  • 国内统一刊号:ISSN:36-1101/R
  • 邮发代号:44-37
  • 获奖情况:
  • 中国期刊方阵“双效”期刊
  • 国内外数据库收录:
  • 中国中国科技核心期刊
  • 被引量:18922